欧洲关节疼痛注射市场预测至 2028 年 - COVID-19 影响和药物（透明质酸、皮质类固醇等）、关节类型（膝、足和踝、肩和肘、髋等）和分销渠道的区域分析（零售药房、医院药房等）
No. of Pages: 125 | Report Code: TIPRE00024544 | Category: Life Sciences
No. of Pages: 125 | Report Code: TIPRE00024544 | Category: Life Sciences
欧洲关节止痛注射剂市场是
一些欧洲国家的 COVID-19 病例数量出现了前所未有的上升，这导致包括关节痛注射剂在内的多种医疗保健产品的多项业务运营和生产活动停止，这对关节痛注射剂市场产生了负面影响。此外，疫情还导致新医疗器械政策的采用停止，临床试验推迟并扰乱了流程。连续两波新冠疫情对欧洲经济活动造成了毁灭性影响。社会疏远和封锁政策的实施导致骨科医院关闭和择期骨科手术患者就诊。这一因素对关节疼痛注射的采用产生了负面影响。此外，供应链中断、封锁延长以及骨科医疗手术的取消也对关节止痛注射市场的增长产生了负面影响。该地区的医院正在取消其他外科手术，以便为 COVID-19 患者提供免费的医疗设施。此外，医护人员中 COVID-19 感染的增加正在导致人员短缺。这些因素对关节疼痛注射剂市场的增长产生负面影响。
欧洲关节疼痛注射剂市场预计将从2021年的5.952亿美元增长到2028年的10.3554亿美元；预计 2021 年至 2028 年复合年增长率为 8.2%。欧洲国家正在成为制药和生物制药行业有吸引力的外包地点。蓬勃发展的国内医药市场和不断增加的在研药品数量进一步为该地区的合同制造商和仿制药生产开辟了新的途径。此外，为了满足不断增长的需求，许多合同组织正在扩大其制造能力。因此，新兴市场为制药企业带来了巨大的潜力和巨大的创收机会。 关节疼痛患病率的增加正在推动关节疼痛注射剂市场的发展。根据“Les Français et les Rhumatismes”的调查结果显示， （风湿病与法国），由 Inserm 和“Ensemble Contre les Rhumatismes”共同开展（共同抗击风湿病），93％的法国人表示患有关节疼痛。此外，它还提到，有12-1300万法国人患有风湿病，其中9-1000万人患有骨关节炎，约60万人患有慢性炎症风湿病，近4000名儿童患有特发性幼年关节炎。因此，关节疾病患病率的上升可能会推动预测期内的市场增长。
按药品分，2020年欧洲关节痛注射液市场份额最大的是透明质酸细分市场。按关节类型分，膝关节细分市场份额最大。 2020年欧洲关节止痛注射剂市场。从分销渠道来看，2020年欧洲关节止痛注射剂市场中医院药房占据最大份额。
准备本欧洲关节疼痛注射市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括中外制药株式会社；生物文图斯公司； Fidia Pharma 美国公司；生化学株式会社；辉凌有限公司；赛诺菲；阿尼卡治疗公司；和 Teva Pharmaceutical Industries Ltd.
欧洲关节止痛注射剂市场 - 按分销渠道划分
Strategic insights for Europe Joint Pain Injection involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 595.20 Million |
| Market Size by 2028 | US$ 1,035.54 Million |
| Global CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Joint Pain Injection refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Joint Pain Injection Market is valued at US$ 595.20 Million in 2021, it is projected to reach US$ 1,035.54 Million by 2028.
As per our report Europe Joint Pain Injection Market, the market size is valued at US$ 595.20 Million in 2021, projecting it to reach US$ 1,035.54 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.
The Europe Joint Pain Injection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Joint Pain Injection Market report:
The Europe Joint Pain Injection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Joint Pain Injection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Joint Pain Injection Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Joint Pain Injection Market
